FDA Recall Terminated Historical recordClass III
ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC, a wholly-owned subsidiary of Eli Lilly and Company, Branchburg, NJ 08876 USA. NDC: 66733-958-23
- Reason
- Labeling: Missing label; potential for missing primary container label on the vial.
- Published
- November 21, 2018
- Distribution
- AL, AZ, CA, KS, LA, MS, OH, OR, TN, TX a…
